Oxford Biomedica Plc (OP: OXBDF )

5.650 UNCHANGED

Streaming Delayed Price Updated: 2:12 PM EDT, Oct 30, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Oxford Biomedica Plc

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

July 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1

July 01, 2022

CNBC Why Kohl’s Shares Are Plunging Today

Via Benzinga

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine

July 01, 2022

Via Benzinga

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program

February 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Oxford Biomedica, Homology Medicines Enter Deal To Expand Viral Vector Offerings

January 28, 2022

London-listed cell and gene therapy Oxford Biomedica Plc (OTC: OXBDF) said it would form a viral vector manufacturing business with Homology Medicines Inc (NASDAQ: FIXX).

Via Benzinga

Oxford BioMedica To Manufacture More Doses Of AstraZeneca's COVID-19 Vaccine, Upgrades 2021 Outlook

May 18, 2021

Oxford BioMedica Plc (OTC: OXBDF) has raised its forecast for cumulative revenues from AstraZeneca Plc (NASDAQ: AZN) by the end of 2021 to more than...

Via Benzinga

Exposures COVID-19

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

Exposures COVID-19

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.